Abstract. The supply of human oocytes is very limited. This restricts not only certain assisted reproduction procedures in IVF clinics where recipients wait for oocytes from donors, but also development of some promising approaches, like therapeutic nuclear transfer with subsequent derivation of patient compatible embryonic stem cells. Moreover, in some patients, collected oocytes exhibit certain specific defects, and logically, we can expect that after fertilization, the embryos arising from these defective oocytes may not develop or that their development might eventually be compromised. For this reason, an increased effort to determine how to repair oocytes is evident in the literature. In general, abnormalities (defects) can be detected in different oocyte components, the zona pellucida, cytoplasm, nucleus (chromosomes) and nucleolus. Whereas defects of a nuclear component are impossible (nuclear DNA) or very hard to repair (nucleolus), zona pellucida abnormalities and cytoplasm defects (for example, if containing mutated mitochondrial DNA, mtDNA) can be repaired in some cases with the help of micromanipulation schemes. In the present article, we will briefly outline the current methodological approaches that can be used to repair the oocyte or one-cell stage embryo. Oocytes and one-cell stage embryos are most commonly used in model animal experiments and are also considered to be the most convenient biological material for relevant therapies in humans. The reason for this is their large size (in mammals, typically about 100 μm) and the relative ease of access to this material. The important aspect is that if the oocyte or one-cell stage embryo is repaired, the resulting cell will be, in theory, normal. This will not be the case, if for example, two-cell stage embryos are manipulated. In this case, both blastomeres must be manipulated to obtain a normal embryo. Logically, this is more complicated from a technical point of view, and thus this approach is not used.The oocytes can be collected either as immature with a prominent nucleus containing one or more nucleoli (germinal vesicle, GV), maturing (with condensed chromosomes, metaphase I, anaphase I or telophase I) or mature (metaphase II). Oocytes are enclosed with a glycoprotein coat known as the zona pellucida. Here, we speculate that only so-called fully-grown oocytes can be used for manipulations because only these cells are able to undergo germinal vesicle breakdown (GVBD) and reach metaphase II (MII) stage. Less advanced oocytes (growing) do not normally undergo GVBD in culture, and if they do, they only reach the metaphase I (MI) stage [1]. Because, mature (metaphase II) oocytes are almost exclusively collected from ovaries in human assisted reproduction, one may expect that this stage would be most commonly used for manipulations. Moreover, use of these oocytes is also advantageous because they are fully developmentally competent due to maturation in their natural environment, follicles. It is well documented that developmental competence decreases ...